
Navarro Discount Pharmacies is owned by CVS Health (NYSE: CVS), which acquired the chain in September 2014. Navarro operates 33 stores in South Florida, Tampa, and Orlando, catering primarily to Hispanic and Latino consumers. The chain was founded in Havana, Cuba in the 1940s by pharmacist Jose Navarro and relocated to Miami's Little Havana neighborhood in the early 1960s. Navarro had annual sales exceeding $340 million at the time of the CVS acquisition. It remains the largest Hispanic-focused pharmacy chain in the United States.
Parent Company
Acquired
2014
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Navarro Discount Pharmacies | CVS Health Corporation | Wholly owned |
Navarro Discount Pharmacies was founded in Havana, Cuba in the 1940s by pharmacist Jose Navarro. The original pharmacy served the local Cuban community with prescription medications and health products. When Fidel Castro's government took power in 1959 and began nationalizing private businesses, the Navarro family left Cuba.
In the early 1960s, the Navarro family established its first U.S. store on SW 8th Street and 13th Avenue in Miami's Little Havana neighborhood. This area was the center of Miami's growing Cuban exile community. The pharmacy catered to the specific needs of Cuban and Hispanic immigrants, offering products and services that mainstream drugstore chains did not carry: Hispanic specialty products, bilingual service, and a welcoming environment for Spanish-speaking customers.
Navarro expanded throughout South Florida over the following decades, opening stores across Miami-Dade and Broward counties. The chain differentiated itself from CVS, Walgreens, and other national pharmacy chains by focusing on the Hispanic market. Navarro stores carry products that traditional drugstores do not: Hispanic grocery items, beauty products from Latin American brands, wireless phones, designer fragrances at discount prices, and a large assortment of over-the-counter medications and vitamins. The stores also feature full-service pharmacies staffed with bilingual healthcare professionals.
By 2014, Navarro had grown to 33 stores and was generating more than $340 million in annual sales. The chain was the largest Hispanic-owned drugstore chain in the United States. Juan M. Ortiz served as CEO at the time of the acquisition. Navarro also operated Navarro Health Services, a specialty pharmacy serving patients with complex or chronic diseases.
On July 14, 2014, CVS Caremark (now CVS Health) announced a definitive agreement to acquire Navarro Discount Pharmacy. The acquisition closed on September 8, 2014. The financial terms were not disclosed. CVS stated that the stores would continue to operate under the Navarro Discount Pharmacy name, preserving the brand identity that had been built over 60 years.
Under CVS Health ownership, Navarro has continued to operate as a separate brand. The chain has not been rebranded to CVS Pharmacy. Store count has remained at 33 locations, primarily in Miami-Dade and Broward counties, with additional stores in Tampa and Orlando. Navarro's website (navarro.com) remains active and offers online shopping for fragrances, beauty products, over-the-counter medications, and Hispanic specialty items.
What does CVS Health own?
CVS Health owns CVS Pharmacy (nearly 10,000 retail locations), CVS Caremark (pharmacy benefits management), Aetna (health insurance), MinuteClinic (retail health clinics), Oak Street Health (Medicare primary care), Omnicare (long-term care pharmacy), Navarro Discount Pharmacies, Longs Drugs, and Coram (infusion and home health services). These brands operate across three segments: Health Care Benefits, Health Services, and Pharmacy and Consumer Wellness.
Is CVS Health publicly traded?
Yes. CVS Health Corporation is publicly traded on the New York Stock Exchange under the ticker symbol CVS. The company is a component of the S&P 500 and is owned by institutional investors, mutual funds, and individual shareholders. There is no parent company or controlling shareholder.
Who founded CVS Health?
The original Consumer Value Store was founded in 1963 in Lowell, Massachusetts by Stanley Goldstein, Sidney Goldstein, and Ralph Hoagland. The company began as a health and beauty products retailer and added pharmacy departments in 1967. It was acquired by Melville Corporation in 1969 and spun off as an independent public company in 1996.
Where is CVS Health headquartered?
CVS Health is headquartered in Woonsocket, Rhode Island, USA. The company's corporate offices, including executive leadership, finance, and strategic operations, are based in Woonsocket, with additional operational offices across the United States.
How many brands does CVS Health own?
CVS Health owns approximately 9 brands across its three operating segments. The most prominent are CVS Pharmacy, CVS Caremark, Aetna, MinuteClinic, Oak Street Health, and Omnicare. The company also operates smaller regional brands including Navarro Discount Pharmacies and Longs Drugs.
Who owns CVS Health?
CVS Health is an independent publicly traded corporation with no parent company. The company is owned by institutional investors, mutual funds, and individual shareholders who hold its NYSE-listed common stock. Major institutional holders include Vanguard Group, BlackRock, and State Street Corporation. There is no founder control or dual-class share structure.
What were CVS Health's recent financial results?
For FY2025, CVS Health reported record revenue of $402.1 billion, up 7.8% year over year, and adjusted EPS of $6.75. In Q2 2026, revenue was $106.1 billion, up 7.3%, with adjusted EPS of $2.58, beating analyst estimates of $1.85. Net income nearly tripled to $3 billion. The company raised its 2026 guidance to at least $414 billion in revenue and adjusted EPS of $7.90 to $8.10.
Has CVS Health made major acquisitions recently?
The most recent major acquisitions were Oak Street Health for approximately $10.6 billion and Signify Health for approximately $8 billion, both in 2023. The largest acquisition in company history was Aetna for approximately $69 billion in 2018. CEO David Joyner has indicated the company has the capital and leadership bandwidth to pursue additional deals across its three business areas.
Navarro does not publish a standalone sustainability report. The chain operates under CVS Health's corporate sustainability framework. CVS Health publishes annual CSR reports covering environmental impact, responsible sourcing, and community health initiatives. However, these reports do not break out Navarro-specific data.
Bilingual Healthcare Access: Navarro's most significant social impact is providing bilingual healthcare services to Hispanic communities in South Florida. All 33 stores employ bilingual healthcare professionals. This addresses a real healthcare access gap: Hispanic Americans are less likely to have health insurance, less likely to have a regular healthcare provider, and more likely to face language barriers in healthcare settings compared to non-Hispanic white Americans, according to data from the Kaiser Family Foundation.
Medication Disposal: Navarro participates in CVS Health's medication take-back programs, which allow customers to safely dispose of unused medications. This prevents environmental contamination from pharmaceuticals entering water systems.
CVS Health Corporate Sustainability: CVS Health has committed to reducing its environmental impact through energy-efficient store design, waste reduction, and responsible sourcing. The company has set targets for reducing greenhouse gas emissions and increasing the use of renewable energy. These initiatives apply to Navarro stores as part of the CVS Health network.
No Brand-Specific Certifications: Navarro does not hold B Corp certification, LEED certification, or other independent sustainability certifications that are publicly verifiable. The chain does not publish carbon footprint data, waste diversion rates, or energy consumption figures specific to its 33 stores.
Navarro does not have a publicly documented list of industry awards. The generic awards listed in some previous versions of this page (e.g., "Community Pharmacy Excellence Awards," "Cultural Competency Awards") appear to be fabricated and cannot be verified through any industry award database or press release.
What can be verified is that Navarro was recognized as the largest Hispanic-owned drugstore chain in the United States at the time of the CVS acquisition in 2014. This designation was reported by the Associated Press, Fortune, and PR Newswire. The chain's 60+ years of continuous service to the South Florida Hispanic community is itself a form of recognition, as few pharmacy brands have maintained community trust for that duration.
Navarro has not been featured on Fortune's Most Admired Companies list, as it is a small division within CVS Health and does not file independent financial reports. The chain has been covered by local South Florida media including the Miami Herald for its community involvement and Hispanic product offerings.
No Brand-Specific Recalls: There have been no FDA or CPSC recalls specific to Navarro Discount Pharmacies as a brand. As a pharmacy chain, Navarro dispenses FDA-approved medications manufactured by pharmaceutical companies. Any recalls of specific medications would be initiated by the manufacturer, not by Navarro. CVS Health's pharmacy operations are subject to FDA and state board of pharmacy regulations.
CVS Health Opioid Settlements (Ongoing): CVS Health, Navarro's parent company, has been involved in opioid-related litigation and settlements. In 2022, CVS Health agreed to pay approximately $5 billion over 10 years to settle opioid claims with states, local governments, and Native American tribes. This settlement applies to CVS Health as a corporation, not to Navarro specifically. However, the reputational impact of opioid settlements affects all CVS Health brands, including Navarro.
CVS Health Store Closures (2022-2024): CVS Health announced plans in 2021 to close approximately 900 CVS Pharmacy stores over three years. This closure program did not include Navarro stores, which were explicitly preserved as a separate brand. However, the broader narrative of pharmacy closures in underserved communities has raised questions about CVS Health's commitment to community pharmacy access. Navarro's continued operation is a counterpoint to this narrative.
Acquisition Integration Concerns: When CVS acquired Navarro in 2014, some community advocates expressed concern that the acquisition would lead to the eventual elimination of the Navarro brand. CVS stated that stores would retain the Navarro name. As of 2026, CVS has kept this promise. However, the lack of expansion beyond 33 stores has led to questions about whether CVS is investing sufficiently in the brand's growth.
No Independent Controversies: Navarro has not been the subject of any major lawsuits, regulatory actions, or public controversies independent of its parent company. The chain operates 33 stores in a specific regional market and maintains a low public profile compared to the CVS Pharmacy brand.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Cvs Health | USA | 1963 | Mass market | United states | All Genders | |
| Cvs Health | United States | 1938 | Mass market | United states | All Genders | |
| Cvs Health | USA | 1981 | Mass market | United states | All-ages | |
| Amazon | USA | 2020 | Mass market | United states | All Genders | |
| Cvs Health | USA | 1984 | Mass market | United states | All Genders | |
| Cvs Health | USA | 2000 | Mass market | United states | All-consumers |
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American pharmacy retail chain and one of the largest pharmacy networks in the United States, owned by CVS Health.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American pharmacy retail chain operating in Hawaii, owned by CVS Health. Approximately 70 stores serving Hawaiian communities.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
Long-term care pharmacy services provider, formerly owned by CVS Health. Filed for Chapter 11 bankruptcy in September 2025 after $949 million False Claims Act judgment.
Healthcare PharmaceuticalsOwned by Amazon.com Inc.
Amazon's online pharmacy service offering prescription medications and home delivery, operating as a division of Amazon.com Inc.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American specialty pharmacy and home infusion services provider, owned by CVS Health since 2014. Coram serves patients with complex conditions requiring specialized infusion therapy.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American retail healthcare clinic chain operating over 1,100 locations within CVS Pharmacy stores, owned by CVS Health. Provides urgent care, vaccinations, chronic disease management, and virtual care services.
Market Positioning: Navarro Discount Pharmacies competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by CVS Health Corporation, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike Navarro Discount Pharmacies which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
Tirosint is privately owned, unlike Navarro Discount Pharmacies which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Bausch + Lomb Corporation
Global eye health company and contact lens manufacturer founded in 1853, known for ULTRA, Biotrue One Day, and INFUSE lens lines. Public on NYSE and TSX under BLCO.
Bausch + Lomb operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
GoodRx operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Herbalife Ltd.
Global nutrition and weight-management brand owned by Herbalife Ltd. and sold through independent distributors in more than 90 markets.
Herbalife operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by EKR Therapeutics, Inc.
Retavase (reteplase) is a prescription thrombolytic medication indicated for acute ST-elevation myocardial infarction. Administered as two 10-unit intravenous bolus injections 30 minutes apart. Currently marketed by Chiesi USA.
Retavase is privately owned, unlike Navarro Discount Pharmacies which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.